Outcome after discontinuing prophylactic antibiotics in children with persistent vesicoureteral reflux
- PMID: 20728116
- DOI: 10.1016/j.juro.2010.04.020
Outcome after discontinuing prophylactic antibiotics in children with persistent vesicoureteral reflux
Abstract
Purpose: Treatment for vesicoureteral reflux remains controversial. Lacking an evidence-based treatment protocol, we offered the option of terminating prophylactic antibiotics in otherwise healthy patients with persistent vesicoureteral reflux at age 5 years or greater. We report outcomes with respect to the urinary tract infection incidence and to whether surgical intervention was eventually done.
Materials and methods: We obtained institutional review board approval to retrospectively review the records of all children with vesicoureteral reflux from December 1999 to February 2009. Of this group we selected children 5 years old or older who had been taken off prophylactic antibiotics. We assessed children with primary vesicoureteral reflux in detail.
Results: The records of 1,217 that we reviewed showed that antibiotics were discontinued in 185 patients, including 160 girls (89%) and 25 boys (11%), at an average age of 6.2 years. Average followup was 2.0 years with recorded followup up to 8 years off prophylaxis. In 50 girls (91%) and 5 boys (9%), urinary tract infection developed after discontinuing prophylaxis. Correction was done in 57 patients, including open repair in 34 and endoscopic injection in 23. Two patients underwent intervention at parent request after an average of 0.7 years of uneventful observation. We identified no parameter predicting patients at risk for urinary tract infection.
Conclusions: Urinary tract infection develops in 29% of patients 5 years old or older with persistent vesicoureteral reflux within 2 years after the cessation of prophylaxis. Most of these cases are febrile. Discontinuing antibiotics is reasonable but a prospective, randomized, long-term, multi-institutional trial is required to determine whether this approach is beneficial.
Copyright © 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Comment in
-
Editorial comment.J Urol. 2010 Oct;184(4 Suppl):1597. doi: 10.1016/j.juro.2010.04.090. Epub 2010 Aug 21. J Urol. 2010. PMID: 20728115 No abstract available.
Similar articles
-
The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux.J Urol. 2000 Jan;163(1):269-72; discussion 272-3. J Urol. 2000. PMID: 10604374 Clinical Trial.
-
Outcome of antibiotic prophylaxis discontinuation in patients with persistent vesicoureteral reflux initially presenting with febrile urinary tract infection: time to event analysis.J Urol. 2010 Sep;184(3):1093-8. doi: 10.1016/j.juro.2010.05.013. Epub 2010 Jul 21. J Urol. 2010. PMID: 20650501
-
Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux.J Urol. 2001 Oct;166(4):1465-9. J Urol. 2001. PMID: 11547114
-
Is antibiotic prophylaxis effective in preventing urinary tract infections in patients with vesicoureteral reflux?Expert Rev Anti Infect Ther. 2010 Jan;8(1):51-8. doi: 10.1586/eri.09.111. Expert Rev Anti Infect Ther. 2010. PMID: 20014901 Review.
-
Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children.J Urol. 2010 Sep;184(3):1134-44. doi: 10.1016/j.juro.2010.05.065. Epub 2010 Jul 21. J Urol. 2010. PMID: 20650499 Review.
Cited by
-
Guidelines for the medical management of pediatric vesicoureteral reflux.Int J Urol. 2020 Jun;27(6):480-490. doi: 10.1111/iju.14223. Epub 2020 Apr 1. Int J Urol. 2020. PMID: 32239562 Free PMC article.
-
Observation of patients with vesicoureteral reflux off antibiotic prophylaxis: physician bias on patient selection and risk factors for recurrent febrile urinary tract infection.J Urol. 2012 Oct;188(4 Suppl):1480-4. doi: 10.1016/j.juro.2012.02.033. Epub 2012 Aug 17. J Urol. 2012. PMID: 22906676 Free PMC article.
-
Evidence-based clinical practice guideline for management of urinary tract infection and primary vesicoureteric reflux.Pediatr Nephrol. 2024 May;39(5):1639-1668. doi: 10.1007/s00467-023-06173-9. Epub 2023 Oct 28. Pediatr Nephrol. 2024. PMID: 37897526 Review.
-
[Primary vesicoureteral reflux].Urologe A. 2013 Jan;52(1):39-47. doi: 10.1007/s00120-012-3079-z. Urologe A. 2013. PMID: 23296463 German.
-
Endoscopic bulking materials for the treatment of vesicoureteral reflux: a review of our 20 years of experience and review of the literature.Adv Urol. 2011;2011:309626. doi: 10.1155/2011/309626. Epub 2011 Apr 6. Adv Urol. 2011. PMID: 21603212 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical